Duloxetine PCD Pharma Franchise Company
Cafoli Lifecare offers a broad Duloxetine PCD pharma franchise built on 16 formulations across capsules and tablets, all manufactured at WHO-GMP certified facilities. This depth gives franchise partners a versatile CNS and pain-management line for psychiatrists, neurologists and physicians.
What is Duloxetine?
Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI). By increasing serotonin and norepinephrine levels in the central nervous system, it treats major depressive disorder and generalised anxiety disorder while also relieving neuropathic and chronic musculoskeletal pain. Read more on MedlinePlus.
Therapeutic Applications
Duloxetine is prescribed for major depressive disorder, generalised anxiety disorder, diabetic peripheral neuropathic pain, fibromyalgia, chronic musculoskeletal pain and stress urinary incontinence. Its dual psychiatric and analgesic role means prescriptions come from psychiatrists, neurologists, diabetologists, orthopaedic surgeons and pain physicians.
Why Duloxetine is a High-Potential Molecule for Distributors
Duloxetine straddles two large, growing markets — mental health and chronic pain — which broadens its prescriber base far beyond a single specialty. Both depression and diabetic neuropathy are long-term conditions, so therapy runs for months or years, driving reliable repeat sales. With 16 formulations available, a distributor can match nearly any dosing need and capture cross-specialty demand from one molecule.
Why Choose Cafoli Lifecare
Cafoli Lifecare provides territory-wise monopoly rights, WHO-GMP certified manufacturing, DCGI-approved formulations, complete promotional inputs and the backing of 1000+ franchise partners across India.
References
- MedlinePlus: Duloxetine
- PubChem: Duloxetine
Our formulations of Duloxetine find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: